Klarsen specializes in data marketing for customer winning and engagement. Thanks to its qualified data and proprietary technologies, it allows its customers to increase their marketing performance and net sales. Klarsen disposes of proprietary assets and qualified and reactive databases, in its network of partners and on its own.

Employees

Sector

IT Services & Consulting

More about the company

Quotes

Date	Price	Change	Volume
14/08/26	€1.340	+21.82%	148,647
13/08/26	€1.100	+22.22%	138,133
12/08/26	€0.9000	+21.62%	80,418
11/08/26	€0.7400	+8.82%	4,116
10/08/26	€0.6800	+14.09%	30,385

Real-time Euronext Paris

More quotes

Income Statement and Estimates

More financial data

Market Closed - Euronext Paris 16:55:00 14/08/2026 BST			5-day change	1st Jan Change
1.340 ^EUR	+21.82%		+124.83%	+54.38%

11-03	Klarsen Reports Earnings Results for the Half Year Ended June 30, 2025	CI
29/04/25	Klarsen Reports Earnings Results for the Full Year Ended December 31, 2024	CI

Market Cap	2.88M 3.33M 2.7M 2.46M 4.62M 318M 4.7M 31.67M 12.38M 159M 12.5M 12.23M 530M	P/E 2023	3.28x	P/E 2024	-86x
Enterprise Value	3.96M 4.58M 3.72M 3.38M 6.36M 438M 6.46M 43.57M 17.03M 219M 17.2M 16.83M 729M	EV / Sales 2023	1.67x	EV / Sales 2024	0.82x
Free-Float	99.21%	Yield 2023 *	-	Yield 2024	-

11-03	Klarsen Reports Earnings Results for the Half Year Ended June 30, 2025	CI
29/04/25	Klarsen Reports Earnings Results for the Full Year Ended December 31, 2024	CI
15/10/24	Klarsen Reports Earnings Results for the Half Year Ended June 30, 2024	CI
29/04/24	Klarsen Reports Earnings Results for the Full Year Ended December 31, 2023	CI
15/03/24	Acticor Biotech Raises EUR8 Million to Fund Emergency Stroke Treatment Development	MT
07/11/23	Acticor Biotech’s Phase 2/3 Trial for Stroke Drug Combo on Track for 2024 Results	MT
27/10/23	Klarsen Reports Earnings Results for the Half Year Ended June 30, 2023	CI
27/04/23	Klarsen Reports Earnings Results for the Full Year Ended December 31, 2022	CI
09/03/23	Acticor Biotech Secures Funding Until November After EUR12 Million Equity Raise; Stock Sinks 17%	MT
23/12/22	Acticor Biotech Seeks To Meet With US FDA Over Phase 2/3 Study Of Stroke Drug	MT
14/12/22	Twitter to shut down newsletter product Revue next year	RE
06/12/22	Acticor Biotech Wins EU Health Agency Nod For Phase 2/3 Stroke Study Design	MT
05/10/22	Klarsen Reports Earnings Results for the Half Year Ended June 30, 2022	CI

03-03	Klarsen : ALKLA information relative au nombre total de droits de vote et d'actions composant le capital	PU
02-25	Klarsen : ALKLA-Information relative au nombre de droits de vote et actions composant le capital	PU
12-10	Klarsen : ALKLA-Attribution gratuite de BSA	PU
12-09	Klarsen : ALKLA-ACTIVITE 3T2025	PU
11-27	Klarsen : ALKLA-Résultat augmentation de capital	PU

Klarsen Share Price

Stocks

ALKLA

FR0011038348

IT Services & Consulting

Valuation: Klarsen

Chart: Klarsen

Latest news : Klarsen

Press Releases: Klarsen

News in other languages: Klarsen

Quotes and Performance

Course Extremes

Managers and Directors: Klarsen

Latest insider transactions

Other IT Services & Consulting

Financials

Company Profile

Quotes

Income Statement and Estimates

08-03	Klarsen : Information réglementée – 2026
07-30	Klarsen : ALKLA – Klarsen ouvre une nouvelle séquence et donne rendez-vous à ses actionnaires le 27 août – 30 Juillet 2026
07-30	Klarsen : ALKLA-CP KLARSEN-nouvelle séquence
07-24	Klarsen : ALKLA – Klarsen annonce la résolution amiable de son litige avec la société PADAM – 24 Juillet 2026
07-24	Klarsen : ALKLA-Résolution litige PADAM à l'amiable

1 day	+21.82%
1 week	+124.83%
Current month	+103.03%
1 month	+252.63%
3 months	+131.03%
6 months	+19.11%
Current year	+54.38%

1 week	0.6	1.34
1 month	0.38	1.34
Current year	0.22	1.34
1 year	0.22	1.34
3 years	0.22	4.03
5 years	0.22	4.03
10 years	0.11	5.4

Manager	Title	Age	Since
Brice Gazeau CEO	Chief Executive Officer	-	-
Patrice Coffe DFI	Director of Finance/CFO	57	30/06/2008
Jean-Pierre Domingo CTO	Chief Tech/Sci/R&D Officer	-	31/12/2012

Director	Title	Age	Since
Patrice Coffe BRD	Director/Board Member	57	13/06/2010
Gérard Parrou BRD	Director/Board Member	74	26/06/2014
Frédéric Bartoli BRD	Director/Board Member	-	22/03/2011

Date	Insider	Type	Main position	Quantity	% Market Cap.
15/03/22	Parrou Julien	Buy		2,617	0.0790%
28/02/22	Julien Parrou-Duboscq	Buy	Chief Executive Officer	3,011	0.0909%
28/02/22	Julien Parrou-Duboscq	Buy	Chief Executive Officer	3,000	0.0905%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
KLARSEN	+21.82%	+124.83%	+37.86%	-62.46%	5.14M
IBM	-1.19%	-1.25%	-1.18%	+65.12%	221B
SNOWFLAKE INC.	-2.51%	-0.48%	+68.76%	+115.18%	114B
ACCENTURE PLC	-0.90%	+0.67%	-28.14%	-43.25%	108B
TATA CONSULTANCY SERVICES LTD.	-0.59%	-3.74%	-21.88%	-31.56%	89.33B
RELX PLC	+1.41%	-3.84%	-28.42%	-2.32%	59.78B
INFOSYS LIMITED	-0.49%	-0.50%	-19.24%	-16.10%	49.52B
NEC CORPORATION	+5.10%	+6.29%	+14.03%	+266.68%	43.08B
FUJITSU LIMITED	+2.43%	+4.52%	+10.15%	+113.03%	41.87B
HCL TECHNOLOGIES LIMITED	-0.73%	+0.25%	-8.71%	+16.14%	38.48B
Average	+2.83%	+13.31%	+2.32%	+42.05%	76.51B
Weighted average by Cap.	+0.14%	+0.09%	+0.81%	+46.94%

	2023	2024
Net sales	5.03M 5.82M 4.72M 4.3M 8.08M 556M 8.21M 55.34M 21.64M 279M 21.85M 21.37M 926M	6.31M 7.31M 5.93M 5.39M 10.14M 699M 10.31M 69.49M 27.17M 350M 27.43M 26.84M 1.16B
Net income	2.75M 3.18M 2.58M 2.35M 4.42M 305M 4.49M 30.29M 11.84M 153M 11.96M 11.7M 507M	-47.76K -55.3K -44.88K -40.82K -76.74K -5.29M -78.01K -526K -206K -2.65M -208K -203K -8.8M
Net Debt	-634K -735K -596K -542K -1.02M -70.24M -1.04M -6.99M -2.73M -35.18M -2.76M -2.7M -117M	1.08M 1.25M 1.02M 924K 1.74M 120M 1.77M 11.9M 4.65M 59.92M 4.7M 4.6M 199M